Search


 
Results 1 - 10 of about 192 for "Highlights".

Update in Endocrinology highlights top diabetes research of ...

... Update in Endocrinology highlights top diabetes research of 2013. Ten studies from 2013 with potential to change endocrinology ...

ADA position statement updates recommendations for diabetic ...

The position statement, an update of one from 2002, outlines the stages of diabetic retinopathy and highlights recommendations on optimal blood ...

Tight BP control associated with improved outcomes in ...

... The study highlights the problem of clinicians' overreliance on guidelines and guidelines' overreliance on limited evidence, according to an ...

Patients with prediabetes diagnosis more likely to change ...

... The authors stated that the impact of prediabetes awareness on the odds of adopting risk-reducing lifestyle factors highlights the special influence ...

ADA updates medical care standards for diabetes | ACP ...

... Section 3, “Comprehensive Medical Evaluation and Assessment of Comorbidities,” is a new section and highlights the importance of assessing ...

Short-term antiplatelet therapy after PCI appears better than ...

... Despite these limitations, the study “highlights the fact that having diabetes itself does not necessarily equate to a requirement for longer duration of ...

Cardiovascular benefits of adding ezetimibe to statin therapy ...

Participants were randomized to receive either ezetimibe or placebo in addition to background simvastatin, and the subgroup of patients with diabetes ...

ADA's updated standards of diabetes care include ...

The American Diabetes Association (ADA)'s 2018 update also recommends that adults with type 2 diabetes and heart disease receive a medication ...

Cardiovascular event rates similar between once-weekly ...

A limitation of the industry-funded randomized trial was the high rate of early discontinuation: 43.0% of patients on exenatide and 45.2% of those on placebo ...

Dapagliflozin appears effective as adjunct therapy in patients ...

Patients with type 1 diabetes taking dapagliflozin for 24 weeks had lower HbA1c level, body weight, and insulin dose than those on placebo, according ...

Result Page: 1 2 3 4 5  Next >